- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Zhejiang Starry Pharmaceutical Co Ltd (603520)
Zhejiang Starry Pharmaceutical Co Ltd stock price live, this page displays SS 603520 stock exchange data. View the 603520 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Zhejiang Starry Pharmaceutical Co Ltd real time stock price chart below.
What Is the Zhejiang Starry Pharmaceutical Co Ltd Stock Price Today?
The Zhejiang Starry Pharmaceutical Co Ltd stock price today is 11.04.
What Is the Stock Symbol for Zhejiang Starry Pharmaceutical Co Ltd?
The stock ticker symbol for Zhejiang Starry Pharmaceutical Co Ltd is 603520.
Is 603520 the Same as $603520?
$603520 is a common way to refer to the Zhejiang Starry Pharmaceutical Co Ltd ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Zhejiang Starry Pharmaceutical Co Ltd Trade On?
Zhejiang Starry Pharmaceutical Co Ltd is listed and trades on the Shanghai stock exchange.
Is Zhejiang Starry Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Zhejiang Starry Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Zhejiang Starry Pharmaceutical Co Ltd share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 603520 quote. (ISIN: CNE1000026N8)
What Is the Zhejiang Starry Pharmaceutical Co Ltd Stock Price Today?
The Zhejiang Starry Pharmaceutical Co Ltd stock price today is 11.04.
What Is the Stock Symbol for Zhejiang Starry Pharmaceutical Co Ltd?
The stock ticker symbol for Zhejiang Starry Pharmaceutical Co Ltd is 603520.
Is 603520 the Same as $603520?
$603520 is a common way to refer to the Zhejiang Starry Pharmaceutical Co Ltd ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Zhejiang Starry Pharmaceutical Co Ltd Trade On?
Zhejiang Starry Pharmaceutical Co Ltd is listed and trades on the Shanghai stock exchange.
Is Zhejiang Starry Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Zhejiang Starry Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Zhejiang Starry Pharmaceutical Co Ltd share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 603520 quote. (ISIN: CNE1000026N8)
Shanghai
Currency in CNY
11.04
-0.12(-1.08%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.88
11.15
52 wk Range
7.96
12.82
Earnings results expected in 14 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.8811.15
52 wk Range
7.9612.82
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.34%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.34%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
603520 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
14.23
Upside
+28.89%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Zhejiang Starry Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical raw materials in China and internationally. It operates through Contrast Agent Series, Quinolone Series, CMO/CDMO, and Others segments. The company offers preparation products comprising iohexol, iopamidol, iodixanol, iomeprol, ioversol, and gadobenate dimeglumine injections; contrast agent APIs and intermediates consisting of iohexol, iopamidol, iodixanol, ioversol, iopromide, iomeprol, gadobenate dimeglumine, gadobutrol, and other products; quinolone APIs and intermediates, such as levofloxacin and levofloxacin hydrochloride; and CMO/CDMO APIs and intermediates, including CIBA, OPAA, 3N, ILC, JSQ, iodine, aza, and loxoprofen sodium. It also engages in technology promotion and application; investment; physical education; and wholesale activities. Zhejiang Starry Pharmaceutical Co.,Ltd. was incorporated in 1997 and is headquartered in Taizhou, China.
Compare 603520 to Peers and Sector
Metrics to compare | 603520 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship603520PeersSector | |
|---|---|---|---|---|
P/E Ratio | −165.3x | 22.9x | −0.5x | |
PEG Ratio | 0.51 | 0.72 | 0.00 | |
Price / Book | 1.9x | 2.4x | 2.6x | |
Price / LTM Sales | 2.0x | 3.2x | 3.2x | |
Upside (Analyst Target) | 27.5% | 29.2% | 45.7% | |
Fair Value Upside | Unlock | 17.3% | 4.8% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 14.23
(+28.89% Upside)
Earnings
Latest Release
Oct 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
447.26M / --
FAQ
What Is the Zhejiang Starry Pharm (603520) Stock Price Today?
The Zhejiang Starry Pharm stock price today is 11.04 CNY.
What Stock Exchange Does Zhejiang Starry Pharm Trade On?
Zhejiang Starry Pharm is listed and trades on the Shanghai Stock Exchange.
What Is the Stock Symbol for Zhejiang Starry Pharm?
The stock symbol for Zhejiang Starry Pharm is "603520."
Does Zhejiang Starry Pharm Pay Dividends? What’s The Current Dividend Yield?
The Zhejiang Starry Pharm dividend yield is 1.34%.
What Is the Zhejiang Starry Pharm Market Cap?
As of today, Zhejiang Starry Pharm market cap is 4.84B CNY.
What Is Zhejiang Starry Pharm's Earnings Per Share (TTM)?
The Zhejiang Starry Pharm EPS (TTM) is -0.08.
When Is the Next Zhejiang Starry Pharm Earnings Date?
Zhejiang Starry Pharm will release its next earnings report on Apr 30, 2026.
From a Technical Analysis Perspective, Is 603520 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Zhejiang Starry Pharm Stock Split?
Zhejiang Starry Pharm has split 3 times.
How Many Employees Does Zhejiang Starry Pharm Have?
Zhejiang Starry Pharm has 1754 employees.
What is the current trading status of Zhejiang Starry Pharm (603520)?
As of Apr 16, 2026, Zhejiang Starry Pharm (603520) is trading at a price of 11.04 CNY, with a previous close of 11.16 CNY. The stock has fluctuated within a day range of 10.88 CNY to 11.15 CNY, while its 52-week range spans from 7.96 CNY to 12.82 CNY.
What Is Zhejiang Starry Pharm (603520) Price Target According to Analysts?
The average 12-month price target for Zhejiang Starry Pharm is 14.23 CNY, with a high estimate of 14.23 CNY and a low estimate of 14.23 CNY. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +28.89% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.